G. Sabatella

发表

Proximity of TPR and NTRK1 rearranging loci in human thyrocytes.

M. Pierotti, C. Rumio, A. Greco, 2005, Cancer research.

Computerized morphometry of the cirrhotic liver: Comparative analysis in primary biliary cirrhosis, alcoholic cirrhosis, and posthepatitic cirrhosis

M. Gambacorta, L. Vizzotto, M. Vertemati, 2004, Microscopy research and technique.

Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis

D. Arnold, B. Kieseier, S. Newsome, 2016, Journal of Neurology.

Analysis of Histological and Immunohistochemical Patterns of the Liver in Posthepatitic and Alcoholic Cirrhosis by Computerized Morphometry

M. Gambacorta, L. Vizzotto, M. Vertemati, 2002, Modern Pathology.

Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 IgG‐Positive NMOSD

Jacqueline Palace, K. Fujihara, H. Kim, 2021, Annals of neurology.

Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT)

P. Marquis, S. Cano, E. Kinter, 2017, Multiple sclerosis journal - experimental, translational and clinical.

Treatment Satisfaction With Disease Modifying Therapies In Multiple Sclerosis: A Systematic Review of Studies Using The Treatment Satisfaction Questionnaire For Medication (Tsqm).

G. Giannattasio, G. Sabatella, J. Petrillo, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a: Obtaining Recommendations Using the Delphi Technique.

D. Centonze, S. Newsome, Deren Huang, 2016, International journal of MS care.

Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis.

G. Phillips, S. Newsome, I. Proskorovsky, 2015, Multiple sclerosis and related disorders.

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder

Jacqueline Palace, D. Wingerchuk, S. Pittock, 2023, Frontiers in Neurology.

Morphometric analysis of primary graft non‐function in liver transplantation

M. Gambacorta, L. Vizzotto, M. Vertemati, 2005, Histopathology.

Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study

R. Benedict, S. Lynch, J. Elkins, 2017, Multiple sclerosis.

Impact of daclizumab versus interferon beta-1a on patient-reported outcomes in relapsing-remitting multiple sclerosis.

Y. Liu, E. Havrdová, T. Vollmer, 2017, Multiple sclerosis and related disorders.

Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE

L. Kappos, S. Greenberg, H. Wiendl, 2017, Multiple sclerosis.